Upfront Therapy for Non‑transplantable Multiple Myeloma in 2026: Decision‑making in an Increasingly Complex Therapeutic Landscape. Can Hematol Today [Internet]. 10 juin 2026 [cité 11 août 2026];5(1):23–33. Disponible à: https://canadianhematologytoday.com/article/view/5-1-Latscha_et_al